Projects per year
Fingerprint
- 1 Similar Profiles
Network
-
-
GENERAL CLINICAL RESEARCH CENTER
Cersosimo, E., Arbeit, L., Carlson, H., Gorevic, P., Palmer, L., Berelowitz, M., Goligorsky, M., Luft, B., La Gamma, E., Hurst, L., Schindler, R., Wilson, T., McNurlan, M. A., Cohn, P., Delisi, L. E., Krupp, L., Cersomino, E., Nachman, S., Volkow, N., Gruber, B., Garlick, P. J., Vincent, R., Lane, D., Gelato, M., Younas, A., Madajewicz, S., Hultin, M., Diaz, A., Edelman, N., Fine, R., Gerber, O., Belman, A., Kaushansky, K., Coyle, P., Badalamente, M., Barraco, R., Parkinson, D., Trilling, J., Vitkun, S., Cohn, P., Adsumelli, R., Carlson, H., Glass, P., Lane, A., Lydic, M. L., Singer, A. J., Perrotta, P., Sheynkin, Y., Ricotta, J., Chang, L., Chen, J., Ding, Y., Langenback, E., Brand, D., Ernst, T., Smith, B., Canli, T., Lawson, W. B., Volkow, N., Ray-Mazumder, S., Steigbigel, R. O. Y., Sedler, M., Coyle, P., Rooney, W., Garry, D. J., Ryan, M., Kovach, J. S., Madajewicz, S., Pomeroy, J., Friedberg, F., Badalamente, M., Wilson, T. H., McNurlan, M. A., Krupp, L., Hurst, L., Wang, G., Perkins, C., Nachman, S., Chen, W., Fowler, J., Goldstein, R., Gelato, M., Tomasi, D. G., Cervo, F., Jabar, R., Anderson, J., Dagum, A., Blader, J., Parodi-Mujica, L. R., De Leon, M. J., Whyte, D., Schwartz, J. E., Chawla, A., Baker, D., Maletic-Savatic, M., Saunders, T., Anschel, D., Rigas, B., Carlson, H., Christodoulou, C., Gold, A., Klein, D., Bahou, W., O'Hea, E., Schlyer, D., Kurland, I. J., Weiming, X., Stone, A. A., Caparelli, E. D. C., Biegon, A., Ricotta, J., Wagshul, M., Lydic, M. L., Jurgens, C., Skopicki, H., Richard, L., Jaber, R., Shumay, E., Dixon, D., Broderick, J. B., Chitkata, M., Bahou, W., Kiefer, D., Morelli, P., Tassiopoulus, A., Lane, A., Mynarcik, D., Singer, A. J., Clark, R. A., Sheynkin, Y. & Blader, J.
6/4/98 → 11/30/11
Project: Research project
-
-
Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT)
Lavynenko, O., Abdul-Ghani, M., Alatrach, M., Puckett, C., Adams, J., Abdelgani, S., Alkhouri, N., Triplitt, C., Clarke, G. D., Vasquez, J. A., Li, J., Cersosimo, E., Gastaldelli, A. & DeFronzo, R. A., May 2022, In: Diabetes, Obesity and Metabolism. 24, 5, p. 899-907 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Antihyperglycemic Algorithms for Type 2 Diabetes: Focus on Nonglycemic Outcomes
Solis-Herrera, C., Cersosimo, E. & Triplitt, C., Aug 1 2021, In: Diabetes Spectrum. 34, 3, p. 248-256 9 p.Research output: Contribution to journal › Article › peer-review
-
Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT
Abdul-Ghani, M., Puckett, C., Adams, J., Khattab, A., Baskoy, G., Cersosimo, E., Triplitt, C. & DeFronzo, R. A., Feb 1 2021, In: Diabetes care. 44, 2, p. 433-439 7 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Anti-inflammatory and anti-proliferative action of adiponectin mediated by insulin signaling cascade in human vascular smooth muscle cells
Cersosimo, E., Xu, X., Terasawa, T. & Dong, L. Q., Sep 1 2020, In: Molecular Biology Reports. 47, 9, p. 6561-6572 12 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Clinical parameters, fuel oxidation, and glucose kinetics in patients with type 2 diabetes treated with dapagliflozin plus saxagliptin
Qin, Y., Adams, J., Solis-Herrera, C., Triplitt, C., Defronzo, R. & Cersosimo, E., Oct 2020, In: Diabetes care. 43, 10, p. 2519-2527 9 p.Research output: Contribution to journal › Article › peer-review